AB
Ally Bridge Group (NY) LLC
13F filer · CIK 0001822947Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$113MU.S. long equity reported on 13F
Positions2310 new · 8 closed
Net flow last quarter-$39.9MBuys minus sells
Top 10 positions weight44.5%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 202623 positions | |||||
| $12.1M | 10.68% | 4.61% | +31.4% | Q4 2025 | |
| $8.16M | 7.22% | 6.92% | +49.8% | Q3 2023 | |
| $5.72M | 5.06% | 0.80% | New | Q2 2026 | |
| $4.04M | 3.57% | 0.03% | Not reported | Q3 2023 | |
| $3.85M | 3.40% | 0.71% | New | Q2 2026 | |
| $3.75M | 3.31% | 1.43% | Not reported | Q3 2022 | |
| $3.38M | 2.99% | 0.08% | -48.3% | Q3 2024 | |
| $3.25M | 2.87% | 0.43% | Not reported | Q2 2024 | |
| $3.18M | 2.81% | 0.33% | Not reported | Q1 2024 | |
| $2.91M | 2.57% | 0.36% | -13.9% | Q1 2026 | |
| $2.77M | 2.45% | 0.28% | Not reported | Q3 2025 | |
| $2.57M | 2.27% | 0.71% | New | Q2 2026 | |
| $2.56M | 2.26% | 0.24% | -66.6% | Q2 2025 | |
| $2.55M | 2.25% | 1.45% | Not reported | Q1 2026 | |
| $2.55M | 2.25% | 0.14% | -65.8% | Q1 2026 | |
| $2.54M | 2.24% | 0.65% | -19.7% | Q2 2024 | |
| $2.52M | 2.22% | 0.07% | Not reported | Q1 2021 | |
| $2.4M | 2.12% | 0.33% | -14.8% | Q4 2025 | |
| $2.15M | 1.90% | Not reported | -54.2% | Q2 2024 | |
| $1.68M | 1.49% | 0.34% | -77.8% | Q4 2025 | |
| $1.67M | 1.47% | 0.49% | -61.8% | Q3 2025 | |
| $683K | 0.60% | 0.70% | New | Q2 2026 | |
| $663K | 0.59% | 5.15% | New | Q2 2026 | |
| Q1 2026Reported May 18, 202621 positions | |||||
| $10.6M | 8.54% | 0.12% | +65.0% | Q4 2022 | |
| $9.97M | 8.06% | 3.78% | Not reported | Q4 2025 | |
| STSLNOSoleno Therapeutics Inc | $6.7M | 5.41% | 0.39% | +19.0% | Q4 2023 |
| $6.26M | 5.05% | 1.69% | +57.9% | Q4 2025 | |
| $5.78M | 4.67% | 0.77% | Not reported | Q2 2025 | |
| $5.67M | 4.58% | 0.19% | Not reported | Q3 2024 | |
| $5.52M | 4.46% | 0.78% | +85.4% | Q2 2025 | |
| $5.26M | 4.25% | 4.62% | +66.1% | Q3 2023 | |
| $5.07M | 4.10% | 0.15% | -17.4% | Q3 2024 | |
| $4.78M | 3.86% | 1.27% | +66.0% | Q3 2025 | |
| $4.23M | 3.42% | 0.53% | New | Q1 2026 | |
| $4.14M | 3.34% | 0.39% | -50.3% | Q4 2025 | |
| $3.86M | 3.12% | 0.81% | Not reported | Q2 2024 | |
| $3.75M | 3.03% | 0.04% | -51.8% | Q4 2025 | |
| $3.68M | 2.97% | Not reported | Not reported | Q2 2024 | |
| $3.63M | 2.94% | 0.42% | New | Q1 2026 | |
| $3.46M | 2.80% | 0.20% | New | Q1 2026 | |
| $2.82M | 2.28% | 1.73% | Not reported | Q3 2022 | |
| $2.23M | 1.80% | 1.00% | New | Q1 2026 | |
| $1.8M | 1.45% | 1.46% | New | Q1 2026 | |
| $1.47M | 1.18% | 0.20% | Not reported | Q2 2022 | |
| Q4 2025Reported Feb 17, 202612 positions | |||||
| $9.44M | 9.83% | 0.09% | New | Q4 2025 | |
| STSLNOSoleno Therapeutics Inc | $7.78M | 8.10% | 0.32% | -44.5% | Q4 2023 |
| $6.98M | 7.27% | 0.78% | New | Q4 2025 | |
| $6.66M | 6.93% | 3.83% | New | Q4 2025 | |
| $5.86M | 6.10% | 0.08% | Not reported | Q4 2022 | |
| $4.84M | 5.04% | 0.18% | Not reported | Q3 2024 | |
| $3M | 3.13% | 0.77% | -56.5% | Q3 2025 | |
| $2.91M | 3.03% | 1.37% | New | Q4 2025 | |
| $2.51M | 2.62% | 0.16% | -75.9% | Q3 2025 | |
| $2.33M | 2.43% | 0.52% | -24.7% | Q2 2025 | |
| $1.98M | 2.06% | 1.73% | Not reported | Q3 2022 | |
| $1.7M | 1.77% | 11.58% | 0.0% | Q3 2023 | |
| Q3 2025Reported Nov 14, 202517 positions | |||||
| STSLNOSoleno Therapeutics Inc | $20.4M | 12.45% | 0.56% | +69.2% | Q4 2023 |
| $15M | 9.12% | 0.14% | Not reported | Q1 2023 | |
| $10.2M | 6.18% | 0.08% | New | Q3 2025 | |
| $8.17M | 4.97% | 0.61% | -48.9% | Q2 2025 | |
| $6.21M | 3.78% | 0.69% | New | Q3 2025 | |
| $5.94M | 3.62% | 0.40% | Not reported | Q3 2023 | |
| $5.88M | 3.58% | 1.07% | -30.9% | Q2 2025 | |
| $5.4M | 3.29% | 2.57% | New | Q3 2025 | |
| $5.26M | 3.21% | 0.97% | +86.6% | Q2 2025 | |
| $4.4M | 2.68% | 0.19% | New | Q3 2025 | |
| $4.26M | 2.60% | Not reported | -50.2% | Q1 2024 | |
| $4.21M | 2.56% | 0.17% | -41.6% | Q3 2024 | |
| $3.39M | 2.06% | 0.71% | -24.2% | Q2 2025 | |
| $2.65M | 1.61% | 11.58% | +367.1% | Q3 2023 | |
| $2.26M | 1.38% | 1.00% | New | Q3 2025 | |
| $2.17M | 1.32% | 0.74% | -15.3% | Q1 2025 | |
| $1.55M | 0.95% | 1.74% | Not reported | Q3 2022 | |
Premium opens every quarter this fund has filed